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A Note on Permutation Tests in Multistage
Association Scans
To the Editor:
There is currently a great deal of interest in performing
whole-genome scans for association between genetic
markers—mainly SNPs—and biological or clinical end
points.1 Often, the most cost-effective strategy for these
studies is a staged design in which a subset of the full
sample is genotyped for all SNPs, and only those SNPs
that show a trend of association are genotyped in the
remainder of the sample.2
For calculating the significance of a genome scan, per-
mutation tests have been suggested to adjust for multiple
testing while preserving the correlation structure among
linked markers.3 In the staged design, however, per-
mutation may result in a marker being selected for the
second stage that had not been selected in the original
analysis. Such a marker will not have been genotyped
in the full sample, and data will not be available to
complete the analysis of the permuted data. Recently,
Lin4 proposed a Monte Carlo method for assessing sig-
nificance in two-stage association scans. The method is
sound but is limited to analysis based on efficient score
functions and does not use permutation. Other inves-
tigators have reported methods to address this problem.5
I wish to draw attention to a property of genome scans
that permits a simple permutation procedure for staged
designs, which is that the sample sizes are large enough
for the null distributions to be asymptotically stable.
Although this observation is trivial, its utility might have
escaped some readers, because of the origins of per-
mutation testing in small-sample inference. It means that
any large subset of the data can be used to simulate the
null distribution. In particular, we can simulate a staged
design with just the first-stage subjects, by using a subset
of the first stage as the simulated first stage, selecting
markers on the basis of that subset, and using the re-
mainder of the first stage as the simulated second stage.
This ensures that full genotype data are always available
and will generate approximately the same null distri-
bution as exists for the full sample.
More precisely, consider a two-stage scan of a set of
markers, M, in a set of subjects, S. In the first stage, all
markers in M are genotyped in a subset of subjects,
. An algorithm, , selects a subset of mark-S O S A(M; S )1 1
ers, M1, on the basis of the data for S1, which are then
genotyped in the remaining subjects . Next,S p S ' S2 1
perform a permutation test by using just the first-stage
subjects as follows. Choose a simulated first-stage sub-
sample, , and a second-stage subsample,∗ ∗S O S S p1 1 2
. After each permutation, select markers∗ ∗S ' S M p1 1 1
. Compute statistics for markers in subjects∗ ∗A(M; S ) M1 1
S1, and compare them with the statistics of the original
data for markers M1 in subjects S. Assume that (i) there
exists an asymptotic joint null distribution of test sta-
tistics on M and (ii) subjects are exchangeable between
S1 and S2. Then, for sufficiently large , , and∗ ∗FS F FS F1 2
, the permutation test will sample from the sameFS F2
null distribution (up to an arbitrary accuracy) as holds
for the two-stage analysis of the full sample S.
For illustration and to confirm that the sample sizes
proposed for genomewide scans are sufficiently large, a
simulation was performed using 1,000 cases and 1,000
controls, which is a smaller sample than current esti-
mates for well-powered scans.6 Chromosomes were
drawn from the phased CEU (CEPH subjects from Utah)
data of chromosome 1, released in phase 1 of the In-
ternational HapMap Project.7 Parental chromosomes
were drawn independently and grouped in pairs, and
gametes were constructed using the supplied recombi-
nation maps, under the assumption of the Kosambi func-
tion with no interference between adjacent SNPs. Chro-
mosomes of children were assigned from the constructed
gametes according to Mendelian transmission and ran-
dom union of gametes and were randomly assigned to
the case or control group. In each replicate, 50% of
subjects were used in the first stage, with the 10% most-
significant markers considered in the second stage.2 The
significance of individual SNPs was calculated by the
trend test,8 and empirical distributions of the maximum
trend statistic were generated from 1,000 replicates.
It is sufficient to show that the two-stage analysis of
the first 500 cases and controls yields the same distri-
bution as the analysis of all 1,000. The distributions
were compared by the two-sample Kolmogorov-Smir-
nov test and also by the Kuiper test, which is more sen-
sitive in the tail. No significant difference was found,
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implying that the null distribution is indeed stable at this
sample size.
The main assumption of this approach is that subjects
are exchangeable between stages, meaning that the null
distribution is independent of the allocation of subjects
to stages. This is true when the sample population is
homogeneous but not when there are systematic differ-
ences between subpopulations. In particular, different
patterns of linkage disequilibrium will invalidate this
approach, as will population stratification in which dif-
ferences in both allele frequency and trait distribution
create a relationship between the null distribution and
the specific subjects analyzed. When the sample consists
of known proportions of different populations, the ap-
proach can be used if the proportions in the original
data are preserved in the permutation test. Also, the
large-sample assumption implies that only common var-
iation is included; this is true for Hapmap SNPs, but, if
rare variation is included, the permutation test will be
less accurate. Nevertheless, for most well-designed scans
of common variation, this approach is a practical and
easily implemented solution for permutation testing in
staged designs.
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